Gatifloxacin‐containing 4‐month ATT regimens vs standard 6‐month ATT regimen
Death from any cause · adults with drug‐sensitive pulmonary tuberculosis
Gatifloxacin‐containing 4‐month ATT regimens showed no clear difference in death from any cause compared with standard 6‐month ATT regimens (moderate certainty).
1 finding from 1 review
- Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis 2019 · Cochrane Headline outcomes onlyRR 0.9 [0.53, 1.53]2 studies · 1886 participantsModerate